Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-21

Clinical Trial Update: Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication [Phase 1]

View source ↗

Summary

Phase 1 trial in healthy volunteers evaluating changes in insulin sensitivity after taking a Tenofovir alafenamide (TAF)-containing antiretroviral regimen. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Technical University of Munich | Conditions: Insulin Resistance | Phase 1 | Status: COMPLETED